NCT06835582
Assessing Concentrations of Methadone and Its Metabolites
Enrolling by Invitation
Not specifiedAges 18–70ObservationalCari Health Inc.Investigator-initiated
~20 participants
Updated 2025-02-19 on ClinicalTrials.gov
What's tested:Methadone
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Measurement of whole blood methadone levels with Lateral Flow Assay
Measured over 1 day
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Charmaine Semenluk, MD, MD · PRINCIPAL_INVESTIGATOR · Synergy Research
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Measurement of whole blood methadone levels with Lateral Flow Assay1 day
whole blood measurement of methadone
- Measurement of whole blood methadone metabolite Levels with Lateral Flow Assay1 day
Whole blood measurement of methadone metabolite
- Measurement of plasma methadone with LC-MS1 day
plasma methadone with LC-MS
- Measurement of plasma methadone metabolite with LC-MS1 day
plasma methadone metabolite with LC-MS